NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,265,544 | -19.5% | 378,020 | +6.4% | 0.04% | -16.3% |
| Q2 2023 | $9,030,785 | +6.2% | 355,263 | +51.0% | 0.04% | +2.4% |
| Q1 2023 | $8,506,493 | +0.9% | 235,311 | +10.5% | 0.04% | -10.6% |
| Q4 2022 | $8,429,929 | +0.5% | 212,877 | +18.2% | 0.05% | +4.4% |
| Q3 2022 | $8,389,000 | -36.4% | 180,032 | -40.2% | 0.04% | -33.8% |
| Q2 2022 | $13,198,000 | -19.1% | 301,125 | +33.5% | 0.07% | -26.1% |
| Q1 2022 | $16,314,000 | +6.7% | 225,545 | +19.6% | 0.09% | +9.5% |
| Q4 2021 | $15,290,000 | +673.4% | 188,598 | +1230.7% | 0.08% | +500.0% |
| Q1 2021 | $1,977,000 | +25.9% | 14,173 | +56.3% | 0.01% | +7.7% |
| Q4 2020 | $1,570,000 | -25.6% | 9,068 | -63.0% | 0.01% | -64.9% |
| Q3 2019 | $2,109,000 | +88.3% | 24,532 | +59.2% | 0.04% | +54.2% |
| Q4 2016 | $1,120,000 | -89.9% | 15,414 | -85.5% | 0.02% | -90.0% |
| Q3 2016 | $11,096,000 | +112.4% | 106,298 | +50.1% | 0.24% | +61.7% |
| Q2 2016 | $5,223,000 | – | 70,816 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |